Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.62 | N/A |
Market Cap | $1.52B | N/A |
Shares Outstanding | 941.96M | N/A |
Employees | 2.76K | N/A |